Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Creso Pharma Limited
  6. News
  7. Summary
    CPH   AU000000CPH2

CRESO PHARMA LIMITED

(CPH)
  Report
SummaryChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Creso Pharma : Subsidiary Receives Craft Designation in Canada

05/17/2021 | 04:34am EDT


© MT Newswires 2021
All news about CRESO PHARMA LIMITED
06/16CRESO PHARMA  : RedLight Holland to Merge Into The HighBrid Lab
MT
06/16RED LIGHT HOLLAND  : Creso Pharma Agree to Merge Businesses; Red Light Holland U..
MT
06/10Creso Pharma Completes Dual Listing on US OTCQB Market; Shares Jump 13%
MT
06/03CRESO PHARMA  : Expands Distribution Deal with Route 2 Pharm to Ecuador; Shares ..
MT
05/26CRESO PHARMA  : Acquisition Target Signs Consultancy Agreement to Advance Entry ..
MT
05/21Creso Pharma Signs Deal with Polvet Healthcare Teodorowski to Market Animal H..
MT
05/18CRESO PHARMA  : Swine Product Set for First Sale in H2; Shares Up 8%
MT
05/17CRESO PHARMA  : Subsidiary Receives Craft Designation in Canada
MT
05/13CRESO PHARMA  : Acquisition Target Secures Additional Synthetic Psilocybin
MT
05/06CRESO PHARMA  : Acquisition Target Enters Test Work Deal With Canadian Research ..
MT
More news
Financials
Sales 2020 2,45 M 1,85 M 1,85 M
Net income 2020 -30,8 M -23,3 M -23,3 M
Net cash 2020 2,79 M 2,11 M 2,11 M
P/E ratio 2020 -2,17x
Yield 2020 -
Capitalization 165 M 125 M 125 M
EV / Sales 2019 6,12x
EV / Sales 2020 65,2x
Nbr of Employees -
Free-Float 92,2%
Chart CRESO PHARMA LIMITED
Duration : Period :
Creso Pharma Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CRESO PHARMA LIMITED
Short TermMid-TermLong Term
TrendsNeutralBearishBullish
Income Statement Evolution
Managers and Directors
NameTitle
Chris Grundy Chief Financial Officer
Adam Blumenthal Non-Executive Chairman
Carole Abel Director-Commercial Operations
Boaz Wachtel Non-Executive Director
James Anthony Ellingford Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
CRESO PHARMA LIMITED-16.67%153
JOHNSON & JOHNSON4.48%433 009
ROCHE HOLDING AG12.33%333 736
PFIZER, INC.6.76%219 989
NOVARTIS AG1.83%212 691
ABBVIE INC.7.82%204 052